About Event:

The 21st Global Biomarkers and Clinical Research Summit, scheduled for September 22-23, 2025, in Paris, France, will bring together leading scientists, clinicians, and industry experts to discuss the latest advancements in biomarker research and their pivotal role in clinical practice. Biomarkers are transforming the landscape of personalized medicine, offering new avenues for early detection, diagnosis, and treatment of diseases. This summit will focus on the integration of biomarkers into clinical trials, drug development, and precision medicine, alongside emerging technologies such as AI-driven diagnostics and next-generation sequencing. THEME: Collaborative Innovations: Building Networks in Biomarker and Clinical Research The event will feature a diverse range of topics including biomarker discovery, validation, regulatory challenges, and their clinical applications in various therapeutic areas such as oncology, cardiology, neurology, and rare diseases. Participants will have the opportunity to engage in keynote lectures, panel discussions, and hands-on workshops, fostering a collaborative environment for knowledge exchange and innovation. With contributions from academia, industry, and regulatory bodies, the summit aims to bridge the gap between research and clinical implementation, paving the way for future breakthroughs in healthcare.